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Abstract  (120 words max) 
Extracellular Vesicles circulate in body fluids of all organisms and participate in intercellular 
cross-organ communication. Tracking and understanding these nanosized objects have been 
hampered by limited resolutive imaging and adapted animal models. The use of zebrafish 
embryos now allows to probe them at unprecedented spatio-temporal resolution, using light 
and electron microscopy. This enables the study of endogenous physiological EVs and 
pathological EVs side by side, and further unravel their biogenesis mechanisms, 
biodistribution, and their target cells throughout the organism. These developments will 
contribute to a better understanding of the in vivo (patho)physiology of EVs 
 
 
Key-words: zebrafish, exosomes, extracellular vesicles, in vivo, high resolution imaging, 
circulation. 
 
 
Highlights (3-5, 900 characters max) 
Multiple lines of evidence indicate that circulating extracellular vesicles (EVs) are involved in 
cell-cell communication in physiologic and pathologic contexts.  
While their cell biology is now better understood in vitro, how they behave at a sub-cellular 
level in complex organisms remained difficult to assess due to the lack of animal models 
adapted to their small size.  
Zebrafish embryos allow to visualize circulating EVs from their cells of origin to their target 
cells and to further explore their fate and function during development or tumor progression. 
In the future, it will certainly contribute to expand the knowledge on EVs at the whole 
organism level. 
 
 
Glossary (450 words max) 
Extracellular vesicle: Generic term encompassing all types of lipid bilayered vesicles 
released outside of cells; Exosomes: extracellular vesicles originating from Multi-vesicular 
bodies; Microvesicles: extracellular vesicles emanating from the plasma membrane; Multi-
Vesicular Body: MVB, late endosome filled with intraluminal vesicles which can either be 
degraded or secreted as exosomes; Mosaic expression: the presence of multiple 
genotypes in a single population of cells, in the context of this review specifically referring to 
the expression of an EV marker of interest in only a fraction of the cells within a given tissue; 
Hagen-Poiseuille equation: Physical law describing the flow forces of a viscous fluid along 
a cylindrical pipe; Patrolling macrophages: Macrophages present in the circulation of 
zebrafish, similar to mouse and human patrolling monocytes; Scavenger receptors: 
Membrane bound receptors involved in the removal of objects from the blood circulation; 
CD63: Tetraspanin protein enriched very broadly in exosomes and small microvesicles; 
pHluorin: pH sensitive GFP variant, whose fluorescence is quenched in acidic 
compartments; Transcytosis: Transport of molecules or vesicles across an epithelial or 
endothelial barrier; YSL: the Yolk Syncytial Layer is a transient, highly secretory, epithelial 
monolayer covering the yolk that forms early during zebrafish development and plays an 
important role in cell fate specification and morphogenesis; Caudal vein plexus: well-
perfused venous endothelial network at the tail end of the fish (see figure 1), formed via 
active angiogenic sprouting and intussusception, as well as fusion, starting at 25 hours post 
fertilization. 
 
 
INTRODUCTION 
Extracellular Vesicles (EVs) are released by most cell types and can elicit a phenotypic 
response in the secreting cell itself (autocrine), in neighbouring or distant receiving cells. 
Over the past two decades, EVs have emerged as versatile mediators of cell-to-cell 
communication, linked to many important physiological and pathological processes, notably 
development and cancer progression [1]. Initially characterized and studied using 
biochemical approaches, research on EVs can now benefit from recent advances in high 
resolution optical microscopy and in vivo models, notably the translucent zebrafish embryo 
[2,3] (Box 1), which allows the analysis of EVs at single-vesicle level in vivo. Descriptive 
observations at this level are likely to open new avenues of research and to generate novel 
hypotheses in the field [4]. Here, we review the recent developments in EV biology provided 
by the use of zebrafish as model organism and discuss a number of open questions that they 
are likely to resolve.  
 
BIOGENESIS AND SECRETION 
EVs are a heterogeneous collection of membranous vesicles enriched in subsets of proteins, 
genetic material and lipids, reflecting the cell type and physiological state of the cell of origin. 
They find their origin either in late endosomes - in which case they are referred to as 
‘exosomes’ (50-150nm in size) - or bud directly from the plasma membrane (PM) – typically 
referred to as ‘microvesicles’ (100~1000nm in size) [5]. Besides these two main members 
of the EV family, other extracellular structures have been described such as apoptotic 
bodies[6], exomeres that are likely not vesicular entities [7], and migrasomes [8] that might 
play a role in zebrafish embryonic development, and have been detected in human serum 
[9]. This review will mainly focus on exosomes and microvesicles. 
The recent progresses within the EV community to deeply characterize the various 
subpopulations of extracellular vesicles has led to the establishment of a common 
nomenclature to distinguish EV subpopulations by their size (large and small EVs) or their 
origin (exosomes vs microvesicles). However, size, density and composition often overlap 
between EV subpopulations. It thus remains to be fully determined to what extent PM derived 
small (s)EVs differ from endosome derived EVs in composition or function. The respective 
contribution of exosomes and microvesicles to the total pool of EVs in vivo remains likewise 
an outstanding question (Box 1). Their high abundance in body fluids coupled to a proposed 
short half-life suggests sustained secretion in vivo [10]. Nonetheless, various reports suggest 
that EVs might be released in a constitutive as well as an induced manner [11,12] and could 
be cell-type dependent. Understanding EV biogenesis, uptake and function greatly benefited 
from in vitro and in vivo (mainly mice, but also Drosophila and C. elegans) studies [5,10]. 
However, live-visualization of EV secretion has long been impossible. This hampers the 
careful assessment of physiological release and uptake rates among cell types and tissues. 
Consequently, a detailed analysis of EV half-life in vivo and careful evaluation of the relative 
contribution of different biogenesis- and release mechanisms lag behind. Recently developed 
approaches now allow visualization of EV release by single cells both in vitro [13,14] and in 
vivo [2,3], even though visualizing the release process in vivo itself remains a technically 
challenging task (Box 2). Concretely, tissue specific expression of an exosomal reporter, 
CD63-pHluorin, revealed that developing zebrafish embryos secrete massive amounts of 
exosomes in a syntenin-a dependent manner. In this context, the zebrafish model adds to 
the very few [15,16] in vivo  studies of EV biogenesis pathways previously described in vitro 
[17]. These exosomes (majorly between 80-120nm in size) are secreted from the yolk 
syncytial layer (YSL) into the blood-stream, a conclusion further supported by in situ 
electron microscopic analysis of this layer. By exploiting tissue specific promoters in 
zebrafish, similar approaches could be used to determine physiological secretion rates and 
local spreading of exosomes and microvesicles for every tissue in vivo (Box 1, Figure 1a). 
Mosaic expression of markers like CD63-pHluorin will further allow close observation of EV 
behaviour directly after secretion, and will be useful to study the impact of the 3D in vivo 
tissue architecture on local EV retention or propagation. Interestingly, levels of circulating 
EVs increase with changes in physiological status [18,19] or during development of various 
pathologies [20–25]. EV secretion levels might thus be increased when homeostasis is 
disturbed and/or EV clearance is perturbed. These hypotheses could be now tackled using 
established zebrafish models of pathologies where EVs are already known to play a central 
role (cancer biology, cardiopathies, neuropathies, host-pathogen interactions, etc...) [26,27]. 
Overall, in vivo imaging of EV release will be instrumental to confirm and further explore EV-
secreting tissues under physiological and pathological conditions (Box 3).   
 
IN TRANSIT: DISSEMINATION AND BEHAVIOR IN BODY FLUIDS 
In vivo imaging at high spatio-temporal resolution could reveal how EVs diffuse around 
secreting cells, how they cross biological barriers, and eventually how they reach the 
circulation before disseminating through the body (Figure 1b-c). For instance, spreading of 
zebrafish melanoma EVs can be tracked at various stages of metastasis in vivo using 
Syntenin2-GFP expressing melanoma cells [3]. In vivo, most cells are not in direct contact 
with the blood but rather with the interstitial fluid compartment that constitutes roughly three 
quarters of the total extracellular body fluid volume. Interestingly, high quantities of 
endogenous YSL-exosomes can be found in the interstitial fluid of zebrafish embryos [2]. 
This compartment might therefore be an overlooked reservoir of EVs, and might play an 
important role during homeostasis or pathology. Likely, it functions as a transit route for EVs 
toward blood vessels or lymphatic vessels, which have recently been shown to contain large 
amounts of EVs [28]. Alternatively, EVs could reach cells distant from blood vessels by other 
mechanisms, such as transcytosis or vascular leakiness (Figure 1b, Box1) [29–32]. Indeed, 
multiple in vivo studies suggest that EVs can cross cellular barriers [29,33], but the precise 
mechanisms involved largely remain to be determined. This is particularly relevant in cancer 
where vessels are known to be abnormally permeable.  
In that context, zebrafish embryos offer a complex and stereotyped vascular network, 
suitable to the fine dissection of EVs behaviour in circulation and long-range dispersion. Fast 
imaging of EVs in the bloodstream reveals that, by contrast to large blood cells, EVs span on 
the entire width of the vessels (See Figure1). Notably, they also flow in close proximity to the 
vessel walls, where their velocities are reduced, according to the Hagen-Poiseuille 
equation, and where they can be found rolling on the surface of the endothelium [2,3]. This 
peculiar distribution is likely to impact the arrest and internalization of EVs that is further 
mediated by their surface adhesion molecules. Besides, we found that circulating EVs arrest 
more efficiently in venous regions than in arteries, suggesting that flow forces directly impact 
their ability to target specific vascular regions [3]. 
 
UPTAKE: ORGANOTROPISM, CELL IDENTITY AND MECHANISMS 
In mice - where detection sensitivity is limiting - EVs injected in the blood circulation 
accumulate in a few specific organs (mostly spleen, liver and lungs) [34]. Furthermore, 
specific organ targeting (and cell type specific targeting within these organs) was reported to 
depend on the integrin repertoire present at the surface of tumour EVs [35]. Further work is 
needed to describe how EV-loaded integrins mechanistically determine such specificity. This 
could be due to an organ-dependent enrichment of adhesion molecules such as integrin 
ligands in specific regions of the vasculature. Alternatively - or in addition - such 
organotropism could be explained by (i) the site of EVs injection, (ii) bloodstream features (ii) 
the capacity of EVs to escape from non-specific scavenging and/or (iv) the permeable nature 
of the target tissue. The size and transparency of the zebrafish embryo, where most organs 
are still being formed (Figure 1a), enables in toto screening that could provide a better 
understanding of EV biodistribution in real-time. In addition, high-resolution microscopy 
allows the identification of receiving cells and the dissection of uptake mechanisms. 
Interestingly, endogenously released exosomes in vivo, as well as pre-labelled tumour EVs 
subsequently injected in zebrafish embryos, are to a large proportion taken up by the caudal 
vein plexus (CVP) [2,3]. The CVP is highly enriched for scavenger endothelial cells (SEC), 
reminiscent of liver sinusoidal endothelial cells (LSECs) within the mammalian liver (Figure 
1c). In addition, this vascular region displays slower hemodynamics, facilitating EV arrest [3]. 
Taking advantage of the high spatio-temporal resolution of the zebrafish model system, it 
was further demonstrated that the uptake by these endothelial cells is likely mediated by 
scavenger receptors in a dynamin-dependent manner, using a dynamin inhibitor and a 
competitive inhibitor for scavenger receptors both applied in vivo [2]. Of note, the interplay 
between receptors engaged on the target cell and specific surface EV proteins could lead to 
the direct activation of signalling pathways and might heavily impact the fate of these EVs. 
Indeed, subsets of EVs could have their primary function by conveying signals to receptors 
located at the PM of the target cell [36,37]. 
These studies likewise indicate efficient uptake of EVs by patrolling macrophages present in 
the lumen of blood vessels of the CVP. Such uptake is likely to occur via filopodia surfing and 
macropinocytosis (a dynamin-independent process, previously described in vitro [38]) and 
‘classical’ endocytosis (Figure 1c). Genetic interference with receptor expression or 
modulation of their trafficking in vivo could provide more insight in these processes. Finally, 
disruption or saturation of clearance mechanisms due to sustained secretion levels of 
pathological EVs might expand the range of target cells [39], and thus “alter” the pathological 
role of these EVs. In this respect, approximation of physiological or pathological levels of EV 
secretion levels in vivo might prove to be pivotal for a true understanding of their significance. 
Live imaging at high resolution in zebrafish could thus help to further unravel cell type 
specific targeting of EVs over time, as well as the details of their dwelling time at the PM and 
the receptor(s) involved. In addition, it will allow a detailed analysis of their uptake and 
trafficking at subcellular level in vivo.  
 
FATE: DEGRADATION, BACK-FUSION AND MESSAGE DELIVERY 
Upon internalization, EVs follow three possible fates: (i) trafficking to lysosomes – leading to 
degradation/recycling of their content; (ii) back-fusion of EVs with the limiting membrane of late-
endosomes - resulting in EV cargo delivery to the cytoplasm and/or integration of exosomal 
transmembrane protein into host cells membrane; (iii) re-secretion of EVs (transcytosis) (Figure 1c, 
Box1). Alternatively, EVs could fuse with the PM of the receiving cell to deliver cargo, but most 
reports indicate uptake before cargo delivery [40]. As the fate of EVs in the target cell will 
directly impact their function, live-imaging combined with Electron Microscopy can be a 
powerful tool to further decipher this aspect of EV physiology. In vivo imaging can be used to 
demonstrate trafficking to late-endosomal compartments by using EV markers tagged with a 
combination of pH-sensitive and non-pH sensitive markers (e.g. pHluorin-CD63-mScarlet 
[41]), in combination with pH-sensitive dyes, such as LysotrackerTM [3] or immuno-EM on 
previously identified recipient cell types/tissues by live-microscopy [2]. Functional cargo 
delivery in vivo can also be visualized using the Cre-stoplight system [42], or by loading EVs 
with other modulators of reporter genes. Interestingly, a recent report using 13C-labeled 
isotope labeling suggests that EV cargo that is (partially) degraded by lysosomes can be re-
utilized by the cell [43]. Indeed, as suggested by accumulation of YSL-exosomes in the 
endothelium following treatment with the lysosomal inhibitor Bafilomycin-A, in situ EM 
analysis showed the presence of EVs in degradative compartments [2]. In the context of 
zebrafish embryo development, uptake and lysosomal degradation of YSL-derived 
endogenous EVs by endothelial cells of the CVP were shown to provide trophic support [2]. 
Even so, trafficking to lysosomal compartments might not exclusively be linked to trophic 
support by degradation of EVs. Accumulation of internalized EVs in late 
endosomes/lysosomes of patrolling macrophages was demonstrated using correlative Light-
Electron Microscopy (CLEM) [3]. Such approach can be efficiently performed in zebrafish 
and thereby unlock some of the remaining secrets related to functional cargo transfer to 
receiving cells. Despite their sorting to lysosomal compartments, tumor EVs could indeed 
induce macrophage activation, suggesting that transfer of EV message/content is likely to 
occur [3]. This phenotypic switch correlates with an increased metastatic outgrowth induced 
by tumor EVs [3]. Likewise, in a near future, the functional impact of EVs, extended to other 
biological questions, could be directly assessed in zebrafish by tracking phenotypic changes 
on receiving cells after EV uptake and modulation thereof [2,3].  
 
CONCLUDING REMARKS 
Despite major recent advances, the exact relevance of exosomes and other EVs in vivo 
remains obscure [44]. Moreover, while pathologies, and especially cancer, are widely 
studied, their exact function in normal physiology remains elusive. In our view, in vivo 
approaches compatible with high spatio-temporal resolution imaging, now possible in 
zebrafish embryos (and hopefully adults in the future), will be instrumental to unlock 
fundamental aspects of the journey and functions of EVs. 
 
 
Text Box 1 | Fishing for answers: outstanding questions in the EV field     
As direct observation of EVs is cumbersome in rodent models, demonstration of their roles in a fully 
physiological in vivo context is still lacking [44]. Multiple questions thus remain unanswered: How 
often are EVs secreted, and what are the triggers? Once secreted, do they travel long-range 
distances or stay in the vicinity of the secreting cell, and why? Are they able to overcome biological 
barriers and what is their half-life? What part of EV physiology eventuates extracellularly without 
requiring internalization, or even cell-independently? How often and how many EVs need to reach a 
target cell to elicit a response? What proportion needs to be internalized or is degraded? Addressing 
these questions requires model systems that allow for resolutive, dynamic observation of EV 
release, trafficking and uptake, as well as tools to modulate EV release and targeting. Rodent 
models are not yet adapted to such tasks, and invertebrate models, despite other advantages, 
mostly lack circulatory systems similar to human. Zebrafish embryos, by contrast, offer many 
advantages, including rapid development, low costs, and amenability to genetic modification, 
natural transparency – allowing non-invasive imaging - and vascular networks. They successfully 
allow probing single EVs at high spatio-temporal resolution by combining high-speed in vivo 
microscopy with resolutive electron microscopy.  
 
Text Box 2 | Technical aspects of EV imaging in vivo  
Recent studies demonstrate that imaging of single EVs in vivo is feasible, at a level that it 
can be used to investigate biological processes [2,3]. Even though the majority of the EVs 
that were studied (50-150nm) are below the resolution limit (~220nm), they can be easily 
detected provided they are bright enough. Temporal resolution of imaging remains an issue. 
Our studies used injection of pre-labelled EVs in combination with a confocal microscope [3] 
as well as tissue specific expression of a genetically encoded CD63-pHluorin in combination 
with a spinning disk microscope [2]. The detection limit for EVs ultimately depends on 
multiple aspects, including the (concentration of the) fluorophore, the size of the EV, the 
imaging speed and depth, the background fluorescence level and the suitability of the 
microscope set-up. In case of genetically encoded EV markers, such as fluorophore-tagged 
tetraspanins, mosaic expression and/or the use of pH sensitive markers can successfully be 
used minimize the background signal coming from expressing cells that would otherwise 
mask the relatively low signals coming from EVs [2,14]. The suitability of the microscope 
setup, finally, will be determined by the numerical aperture of the objective, laser wavelength 
and intensity, and the sensitivity of the camera. Finally, the fact that extracellular (non-
endocytosed) EVs are motile (i.e. move with Brownian motion in absence of flow, or take the 
speed of the flow) adds temporal restrictions to the exposure time. In addition to in vivo 
photonic imaging, EVs can be observed by electron microscopy in fixed samples. In situ 
immunolabeling can further discriminate between different EVs subtypes or identify tagged 
EVs [2], while correlation between light and electron microscopy (CLEM) offers the possibility 
to combine in vivo tracking of EVs with their high resolution imaging [3].Finally, super-
resolution microscopy will in some specific cases provide improved z- and lateral resolution 
to refine intracellular trafficking of EVs in producing and receiving cells [45].     
 
Text Box 3 | Pathological models in ZF      
Zebrafish can be used to recapitulate various aspects of human pathologies. While sharing 
less homology with humans than rodents, 71.4% of human genes and 82% of human genes 
involved in diseases have at least one zebrafish orthologue [46]. This opens the possibility 
for genetic cancer models for brain tumors, including glioma, but also for melanoma, 
malignant peripheral nerve sheath tumors, leukemia (T-ALL, B-ALL, AML), thyroid cancer, 
colon adenoma and hepatocellular carcinoma, pancreatic cancer, rhabdomyosarcoma 
[47,48]. This also includes the possibility of xenografting human cancer cells [49,50], in 
embryos or in immunodeficient adults [51], using zebrafish as real-time ‘avatar’ to predict 
individual patient’s tumor responses to therapy, opening the door to personalized medicine 
[48]. Apart from cancer, zebrafish can also be used as a model system to study host–
pathogen interactions [52], including the possibility to study the functionality of Outer 
Membrane Vesicles in zebrafish [53], cardio-vascular pathologies [54], gastrointestinal 
diseases [55], kidney diseases [56], muscular diseases [57], metabolic disorders [58] and 
neurological disorders [59], including Alzheimer’s disease [60]. In most of these pathologies, 
EVs are suspected to contribute to disease progression, but their direct contribution in vivo 
remains to be determined. 
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Figure Legends 
Figure 1: Zebrafish, a new model to unlock the secrets of EVs in vivo. Multiple questions 
surrounding EV biology could be addressed using zebrafish embryos. A) Schematic depiction of a 
48hpf zebrafish embryo indicating the organs that are being formed. B) EV secretion and dispersion 
can be analysed in zebrafish embryo. The electron microscopy picture (Verweij et al. Dev Cell 2019) 
illustrates the release of extracellular vesicles (pointed by black arrows) from the Yolk Syncytial 
Layer (YSL) to the blood circulation (indicated by (1) and a dashed box in the embryo scheme). 
Below, the scheme shows the processes that can be studied by tracking labelled exogenous (in blue) 
and endogenous EVs (eosomes in green; microvesicles in red) at single EV resolution, including 
secretion and local dispersion. C) Zebrafish embryo can be used to study distant uptake and fate of 
labelled EVs. The picture is taken from live confocal microscopy in the Caudal Vein Plexus (CVP), 
(indicated by (2) and a dashed box in the embryo scheme) of transgenic embryos expressing a red 
endothelium and green macrophages injected with Cyan fluorescent EVs (Hyenne V. unpublished). 
Similar to (B), the scheme below illustrates the events that can be analysed in vivo. 
 
 
 
